Causes of TIPS dysfunction
- PMID: 19020247
- DOI: 10.2214/AJR.07.3534
Causes of TIPS dysfunction
Abstract
Objective: Transjugular intrahepatic portosystemic shunt (TIPS) creation is an effective method to control portal hypertension. TIPS creations with bare stents have shown limited and unpredictable patency. In nearly all cases of rebleeding or recurrent ascites after TIPS creation, there is shunt stenosis or occlusion. The purpose of this article is to review the biologic and technical factors that predispose to TIPS failure and how the use of an expandable polytetrafluoroethylene (PTFE)-covered-stent has significantly improved TIPS patency.
Conclusion: Biologic and technical factors may predispose to shunt failure. The combination of improved technique and expandable PTFE has significantly improved TIPS patency. The need for follow-up venography and secondary interventions has been reduced significantly as a result of improved shunt patency.
Similar articles
-
Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.Am J Gastroenterol. 1997 Sep;92(9):1444-52. Am J Gastroenterol. 1997. PMID: 9317060
-
Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.Eur J Radiol. 2005 Jul;55(1):120-4. doi: 10.1016/j.ejrad.2004.10.007. Eur J Radiol. 2005. PMID: 15950109
-
Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.Acad Radiol. 2018 Jul;25(7):925-934. doi: 10.1016/j.acra.2017.11.020. Epub 2018 Jan 17. Acad Radiol. 2018. PMID: 29373208
-
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500. J Clin Gastroenterol. 2007. PMID: 17975487 Review.
-
The transjugular intrahepatic portosystemic shunt: an update.AJR Am J Roentgenol. 2012 Oct;199(4):746-55. doi: 10.2214/AJR.12.9101. AJR Am J Roentgenol. 2012. PMID: 22997364 Review.
Cited by
-
Use of Intravascular Ultrasound to Improve Diagnosis and Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction in Patients in the Long-term Follow-up.Euroasian J Hepatogastroenterol. 2022 Jan-Jun;12(1):50-56. doi: 10.5005/jp-journals-10018-1374. Euroasian J Hepatogastroenterol. 2022. PMID: 35990871 Free PMC article.
-
Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation.Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S150-S158. doi: 10.21037/cdt.2017.10.03. Cardiovasc Diagn Ther. 2017. PMID: 29399518 Free PMC article.
-
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2. Cochrane Database Syst Rev. 2023. PMID: 37531575 Free PMC article.
-
Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.World J Gastroenterol. 2014 Jan 21;20(3):774-85. doi: 10.3748/wjg.v20.i3.774. World J Gastroenterol. 2014. PMID: 24574750 Free PMC article.
-
Transjugular intrahepatic portosystemic shunt and non-selective beta-blockers act as friends or foe in decompensated cirrhosis: A comparative review.World J Gastrointest Surg. 2025 Apr 27;17(4):103395. doi: 10.4240/wjgs.v17.i4.103395. World J Gastrointest Surg. 2025. PMID: 40291858 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
